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American Heart Association GuidelinesWe would like to thank Dr. Pericas and colleagues for
their interest in our paper (1). We agree that entero-
coccus as an etiology of infective endocarditis (IE) is
important due to increasing prevalence of IE (2) and
evolving resistance to antibiotics. Hence, we do
appreciate the suggestion to look at enterococcus as a
speciﬁc subgroup and will include it in a future
analysis. Monitoring the trend in enterococcal endo-
carditis will provide better insights into IE epidemi-
ology and may have important implications in the
prevention of IE.*Sadip Pant, MD
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Still an Invisible Factor?We read with great interest the paper by Taruya et al.
(1) in a previous issue of the Journal. The authors
should be congratulated for their detailed work. Uti-
lizing as an imaging modality the light-based optical
coherence tomography (OCT), they have shown that
vasa vasorum (VV) and intraplaque neovascularization
structure volumes differ between various plaque
characteristics. In particular, the VV volume is posi-
tively correlated with ﬁbrous plaque volume, whereas
speciﬁc 3-dimensional structures of intraplaque
neovessels are associated with plaque vulnerability.
Although we think that this work represents a
signiﬁcant contribution to the ﬁeld of VV, we havesome comments regarding the ﬁndings and their
interpretation.
On the basis of our ﬁndings, we believe that im-
ages of VV and intraplaque neovessels obtained
during the short time interval of 2 to 3 s (pull back
imaging with OCT) represent only a part of the total
VV and intraplaque neovessel existing network
(external and internal) that nourishes the athero-
sclerotic plaque (2). Indeed, we have shown in an
almost operator-independent quantitative analysis
of contrast-enhanced intravascular ultrasound that
maximal perfusion of the coronary atherosclerotic
plaque through the existing VV network occurs at
20 s post-intracoronary contrast injection (2). There-
fore, the obtained images and calculated volumes of
VV and intraplaque neovessels may not reﬂect the
total volume that perfuses the plaque, and as a
result, correlations between study volumes of VV
and atherosclerotic plaques may not be ideal.
Furthermore, apart from the increased intracoronary
pressure produced by continuous contrast infusion
during OCT imaging on neovessel volume, rheolog-
ical intraluminal conditions can be instantly altered
by hemodynamics and heart movement, leading to
constant ﬂuctuation of volume. Additionally, the
ﬂashed x-ray contrast may inﬂuence the image
that is received and analyzed further off-line,
by interacting within the studied microvessels, as
the analyzed frame is captured simultaneously with
ﬂashing.
The ﬁndings of Taruya et al. (1) add signiﬁcant in-
formation to previously published data indicating
the key role of neovascularization within the athero-
sclerotic plaque (3). Doubtless, VV neovascularization
imaging and assessment, either with OCT or contrast-
enhanced intravascular ultrasound, can be estab-
lished as a valuable tool for vulnerable plaque
detection and its therapeutic regression.*Manolis Vavuranakis, MD, PhD
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Still an Invisible Factor?We deeply thank Drs. Vavuranakis, Kalogeras, and
Tousoulis for their interest in our recent paper (1). Any
current intravessel optical coherence tomography
(OCT) systems require injection of ﬂushing medium,
resulting in high pressure in the arterial lumen and
consequentlywithin the arterialwall. Aswementioned
in the limitations section of our paper, intramural
pressure gradient can result in compression of some
of the vasa vasorum (VV) and intraplaque neovessels
(2). Therefore, the images obtained of VV and intra-
plaque neovessels may not precisely reﬂect the same
pressure condition. However, the high pull back speed
(20 cm/s) of frequency-domain OCT brought about
the short time period for maximal pressure ﬂushing.
Keeping in mind the variable volume of the VV and
intraplaque neovessels, we analyzed all images for re-
gion of interest. It may not be necessary to determine
ideal perfusion pressure because the correlations
would likely be similar under the same conditions.
Contrast-enhanced ultrasound (CEUS) is also avail-
able for analyses of neovessels. Previously published
data indicate that CEUS provides a signiﬁcant increase
in the signal-to-noise ratio andmight permit enhancedidentiﬁcation of the vasculature within the vessel
walls and within the plaque (3). However, for coronary
arteries, the spatial resolution of CEUS seems to be
enough for adventitial VV but unsatisfactory to depict
intraplaque neovessels.
We agree that future studies are needed in the same
segment and lesion to assess the serial role of the VV
and neovessels. We think that the 3-dimensional
structure transition of VV and intraplaque neovessels
might have a clinical application to determine the
progression of atherosclerotic plaque, whether using
frequency-domain OCT or CEUS.Akira Taruya, MD
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